<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161531">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02020395</url>
  </required_header>
  <id_info>
    <org_study_id>GI peptides obese adolescents</org_study_id>
    <nct_id>NCT02020395</nct_id>
  </id_info>
  <brief_title>Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents</brief_title>
  <official_title>Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Children's Hospital Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to examine ghrelin, amylin, glucagon and glucagon-like
      peptide (GLP)-1 responses to a test meal in lean and obese individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary hypothesis is that obese adolescents have a disturbed balance of hormones
      associated with appetite regulation with less suppression of ghrelin and attenuated
      stimulation of GLP-1 secretion in response to meal intake compared to lean normal weight
      controls. A second aim of the study was to test which gastrointestinal peptides are most
      associated with insulin resistance.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Comparison of gastrointestinal peptide secretion in normal weight and obese adolescents</measure>
    <time_frame>2 hours blood sampling</time_frame>
    <safety_issue>No</safety_issue>
    <description>Relation of GLP-1 release to insulin secretion in normal weight and obese adolescents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between gastrointestinal peptides and insulin release</measure>
    <time_frame>2 hours blood sampling</time_frame>
    <safety_issue>No</safety_issue>
    <description>Dynamics of gastrointestinal peptide secretion including Tmax and Cmax</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Endocrine System Diseases</condition>
  <arm_group>
    <arm_group_label>Test meal (500 kcal)_normal weight</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>ham sandwich chocolate cream orange juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test meal (500 kcal)_obese weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ham sandwich chocolate cream orange juice</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>test meal (500 kcal)</intervention_name>
    <description>whole wheat bread (68 g), butter(10 g), ham (25 g); chocolate cream (90 g); orange juice (200 mL)</description>
    <arm_group_label>Test meal (500 kcal)_normal weight</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>test meal (500 kcal)</intervention_name>
    <description>whole wheat bread (68 g), butter(10 g), ham (25 g); chocolate cream (90 g); orange juice (200 mL)</description>
    <arm_group_label>Test meal (500 kcal)_obese weight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  caucasian youth

          -  pubertal Tanner stage x, y, or z

        Exclusion Criteria:

          -  fasting plasma glucose &gt; 7.0 mmol/L

          -  significant illness

          -  taking medications
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Beglinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Gastroenterology and Hepatology, University Hospital Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel, Division of Gastroenterology and Hepatology</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>December 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endocrine System Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
